APA

Henderson S. J., Konkar A., Hornigold D. C., Trevaskis J. L., Jackson R., Fritsch Fredin M., Jansson-Löfmark R., Naylor J., Rossi A., Bednarek M. A., Bhagroo N., Salari H., Will S., Oldham S., Hansen G., Feigh M., Klein T., Grimsby J., Maguire S., Jermutus L., Rondinone C. M. & Coghlan M. P. (20171107). Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates. : Diabetes, obesity & metabolism.

Chicago

Henderson S J, Konkar A, Hornigold D C, Trevaskis J L, Jackson R, Fritsch Fredin M, Jansson-Löfmark R, Naylor J, Rossi A, Bednarek M A, Bhagroo N, Salari H, Will S, Oldham S, Hansen G, Feigh M, Klein T, Grimsby J, Maguire S, Jermutus L, Rondinone C M and Coghlan M P. 20171107. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates. : Diabetes, obesity & metabolism.

Harvard

Henderson S. J., Konkar A., Hornigold D. C., Trevaskis J. L., Jackson R., Fritsch Fredin M., Jansson-Löfmark R., Naylor J., Rossi A., Bednarek M. A., Bhagroo N., Salari H., Will S., Oldham S., Hansen G., Feigh M., Klein T., Grimsby J., Maguire S., Jermutus L., Rondinone C. M. and Coghlan M. P. (20171107). Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates. : Diabetes, obesity & metabolism.

MLA

Henderson S J, Konkar A, Hornigold D C, Trevaskis J L, Jackson R, Fritsch Fredin M, Jansson-Löfmark R, Naylor J, Rossi A, Bednarek M A, Bhagroo N, Salari H, Will S, Oldham S, Hansen G, Feigh M, Klein T, Grimsby J, Maguire S, Jermutus L, Rondinone C M and Coghlan M P. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates. : Diabetes, obesity & metabolism. 20171107.